Mankind Pharma launches drug for treatment of infertility in India
With the launch, the company has become the first Indian and second global...
Central drugs regulator asks states, UTs to stop online sale of medicines
DCGI has asked all drug regulators in states and Union Territories ...
Strides Pharma gets tentative nod from USFDA for pain relieving drug
Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food & Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.
Biocon, Mylan launch cancer drug in US market
Ogivri, available in a 420mg multi-dose vial and a 150mg single-dose vial, will be used for treatment of all types of breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma).
Facebook groups fuel illegal gun sales: Chicago police
Chicago police say private Facebook groups have "emboldened" sellers of illegal drugs and guns to connect with potential buyers on the socia...
Sun Pharma gets partial relief from US court in litigation involving three generic drugs
Drug major Sun Pharma is a defendant in a multi-district litigation brought by various classes of plaintiffs in the US District Court (District of Massachusetts), alleging a delay in the market entry for three generic drugs -- Valganciclovir, Valsartan and Esomeprazole. The company said it would continue to vigorously defend against all claims.
Over 256 kg drugs seized, dozen arrested in narco cases across country: NCB
NCB sleuths have seized over 256 kg narcotics and arrested a dozen people in connection with drug trafficking cases across the country over the last fortnight.
Biocon, Mylan get USFDA nod for pegfilgrastim drug substance licence
This additional approval of its new manufacturing facility for pegfilgrastim in Bengaluru will enable the biotechnology major to enable its arm Biocon Biologics and Mylan to scale up capacity multi-fold and address the growing market opportunities in US and other global markets.
This firm is hunting for a cancer cure
Zumutor, the Boston-headquartered startup, which was founded by second-time entrepreneur and former Biocon executive Kavitha Iyer Rodrigues in June 2015, has US and EU patents for this platform. “Our robust IP portfolio has a landscape beyond 2034,” she said.
Pharma Inc agrees to cap margins on non-price control drugs at 30%
Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP.
Glenmark Pharma gets USFDA nod for diabetes management drug
"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for metformin hydrochloride extended release tablets USP, 500 mg and 1000 mg, the generic version of Glumetza extended release tablets, 500 mg and 1,000 mg, of Salix Pharmaceuticals Inc," the drug maker said in a filing to BSE.
Fake news bigger menace than paid news: Prakash Javadekar
Speaking at an event organised by the Press Council of India to observe National Press Day and confer National Awards for Excellence in Journalism, the union minister for information and broadcasting also touched upon the issue of "lynching" and how only "one kind of lynching" was being talked about.
Govt to initiate talks with stakeholders on drug trade margins
The Department of Pharmaceuticals along with the Drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA) will discuss the issue of TMR with the stakeholders, in an effort to reduce prices of medicines & medical devices. The trade margin is the difference between the price at which the manufacturers/importers sell to stockists and the price charged to consumers.
Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker
The deal shows Novartis CEO Vas Narasimhan is ready to spend billions on not just rare disease treatments, as it did in 2018 when it paid $8.7 billion for gene therapy specialist AveXis, but also for cardiovascular medicines aimed at a market with potentially millions of patients.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service